Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
In 2023, the FDA designated BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by commercial pharmaceutical companies, and there is insufficient evidence regarding potential harm to humans
Theendakara V, Peters-Libeu CA, Spilman P, Poksay KS, Bredesen DE, Rao RV
Those with Wilson's disease or copper metabolism disorders should avoid GHK-CU entirely
Se comercializa como reactivo de investigacin (RUO) para el estudio del metabolismo del dinucletido de nicotinamida y adenina (NAD+) y de la enzima nicotinamida N-metiltransferasa (NNMT), sobre la cual acta como inhibidor selectivo
Visible outcomes typically include smoother texture, brighter skin tone, improved firmness, reduced acne scarring, diminished pore size, and enhanced hydration retention
It is a naturally occurring tripeptide that binds copper ions to form a stable metallopeptide complex
